Form 4 holding
Chief Technology Officer
Cartesian Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 62,258
- Estimated value
- $1,047,939
- Report date
- 06 Jan 2025
- Price
- $16.83
- Ownership
- Direct
Metin Kurtoglu - Chief Technology Officer at Cartesian Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Technology Officer
- Issuer ticker
- RNAC on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Metin Kurtoglu since 17 Jul 2025
Reported holdings for Metin Kurtoglu in Cartesian Therapeutics, Inc.
Form 4 holding
Chief Technology Officer
Cartesian Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 79,099
- Estimated value
- $62,488
- Report date
- 10 Dec 2024
- Price
- $0.7900
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Technology Officer
Cartesian Therapeutics, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 47,400
- Estimated value
- Report date
- 02 Jan 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Metin Kurtoglu in Cartesian Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.